Repurpose and More Store Donations AmazonSmile Contact Us

FDA Issues Warning About Oral Drug Products

Recent News

Rochester Pyramid Model Leadership Summit

June 14 2018

Promoting Social and Emotional Competence and Addressing Challenging Behaviors July 12th 5:00pm-7:00pm July 13th 7:30am-4:00pm St. John Fisher College Keynote Speaker: Mary Louise Hemmeter, PhD Register for this exciting opportunity to learn how the Pyramid Model aligns with trauma-informed care, supports children’s resilience, and strengthens children’s social and emotional competencies. The registration for the Pyramid […]

Read More >
Upcoming Events
    Course Calendar

    Rochester Business Alliance

    FDA Issues Warning About Oral Drug Products

    The U.S. Food and Drug Administration (FDA) is warning that over-the-counter (OTC) oral drug products containing benzocaine should not be used to treat infants and children younger than 2 years. The risk of a serious and potentially fatal blood disorder prompted FDA action on OTC oral benzocaine products used for teething and mouth pain and prescription local anesthetics.

    Visit the FDA website for more information.

    Comments are closed.